Global cardiovascular ultrasound imaging market is expected to reach US$ 1.72 billion in 2023

Market Research Future published a Half-Cooked Research Report on “Global Cardiovascular Ultrasound Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Cardiovascular Ultrasound Market and are profiled in MRFR Analysis.

Global Cardiovascular Ultrasound Market - Overview

ultrasound imaging system market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favouring the growth of this market. Increase in demand of cardiovascular ultrasound imaging system in hospitals for diagnosis of heart disease or before any surgical procedure favour the growth of this market.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1548 .

Cardiovascular diseases gain a huge attention due to increasing prevalence. Due to increasing number of death from cardiovascular diseases, number of companies are in a race for the introduction of the better devices and accessories for the treatment. Moreover, increasing prevalence of the cardiovascular is expected to support the growth of the market. Diabetes & obesity are the major causes for cardiovascular diseases. Furthermore, increasing number of patients suffering from these diseases lead to increase in the prevalence of cardiovascular diseases, ultimately increase the demand for the cardiovascular devices which will fuel the growth of the market. However, growing Cardiovascular (CV) disease burden is the major factor contributing in the growth of the market and is likely to increase in coming years due to growing patient and geriatric populations.

According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to findings from the WHO, in 2015, 82% of the total deaths were occurred in low- and middle-income countries. According to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die from heart disease each year, which accounted for 1 in every 4 deaths. According to findings from the WHO in 2014, approximately 422 million people suffered from diabetes. Beside this, globally 39% of adults aged 18 years and over were overweight in 2016, and 13% were obese.

Browse Complete Report at https://www.marketresearchfuture.com/reports/cardiovascular-ultrasound-market-1548 .

June, 2017 - Hitachi healthcare Americas introduced the “LISENDO 880,” new premium 2D and 3D cardiovascular ultrasound system at the American Society of Echocardiography 2017 in Baltimore, Maryland. AS per company reports, the advanced architecture of the LISENDO 880 offers state of the art probe technology for 2D and 3D imaging, a high performance OLED display, premium image optimization parameters such as e-Focus and Pure Symphonic Architecture to capture the subtlest of changes and produce the highest-quality sound. There are many features of LISENDO 800 such as dynamic 3D evaluation, LVeFlow, Dual Gate Doppler, Eyeball EF, 2DTT, and FAM, provide solutions for the most difficult clinical challenges. Additionally, applications like VFM, eTracking and Wave Intensity move hemodynamic evaluations beyond the basics.

June, 2014 - GE Healthcare, had received clearance from the Food and Drug Administration (FDA) for its Vivid T8TM cardiovascular ultrasound device. As per reports, GE had enhanced the reach of the Vivid T8 by combining the established cardiac imaging capabilities of GE Vivid systems with exceptional performance of the company's LOGIQTM systems. The Vivid T8, cardiovascular ultrasound system is rugged, reliable, robust, and is affordable and convenient to use. It had been designed and rigorously tested for high reliability, the Vivid T8, mobile system intended for use in a variety of traditional as well as harsh, demanding environments. It delivers a hardy robustness that stands up to the challenges of even the busiest ultrasound imaging practices and clinical settings.

Global Cardiovascular Ultrasound Market- Regional Analysis

Depending on geographic region, cardiovascular ultrasound market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Globally Americas hold the largest market share for cardiac rehabilitation devices. North American region is the leading market in the America region. Europe is the second-largest market globally for cardiac rehabilitation devices which is expected to continue its growth in the near future. Asia pacific region is expected to be fastest growing region in cardiac rehabilitation devices market. However, the Middle East & Africa holds the least share of the cardiovascular ultrasound imaging market due to less availability of funds, limited medical facilities, and deprived political conditions in Africa.

About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
P: +1 646 845 9312
W: www.marketresearchfuture.com
sales@marketresearchfuture.com

This release was published on openPR.